Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG.
- Campanella S Laboratoire de Psychologie Médicale et d'Addictologie, ULB Neuroscience Institute (UNI), CHU Brugmann-Université Libre de Bruxelles (U.L.B.), Belgium.
- Arikan K Kemal Arıkan Psychiatry Clinic, Istanbul, Turkey.
- Babiloni C Department of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Italy.
- Balconi M Research Unit in Affective and Social Neuroscience, Department of Psychology, Catholic University of Milan, Milan, Italy.
- Bertollo M BIND-Behavioral Imaging and Neural Dynamics Center, Department of Neuroscience, Imaging and Clinical Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.
- Betti V Department of Psychology, Sapienza University of Rome, Fondazione Santa Lucia, Rome, Italy.
- Bianchi L Dipartimento di Ingegneria Civile e Ingegneria Informatica (DICII), University of Rome Tor Vergata, Rome, Italy.
- Brunovsky M National Institute of Mental Health, Klecany Czech Republic.
- Buttinelli C Department of Neurosciences, Public Health and Sense Organs (NESMOS), Sapienza University of Rome, Rome, Italy.
- Comani S BIND-Behavioral Imaging and Neural Dynamics Center, Department of Neuroscience, Imaging and Clinical Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.
- Di Lorenzo G Laboratory of Psychophysiology and Cognitive Neuroscience, Chair of Psychiatry, Department of Systems Medicine, School of Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
- Dumalin D AZ Sint-Jan Brugge-Oostende AV, Campus Henri Serruys, Lab of Neurophysiology, Department Neurology-Psychiatry, Ostend, Belgium.
- Escera C Brainlab-Cognitive Neuroscience Research Group, Department of Clinical Psychology and Psychobiology, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
- Fallgatter A Department of Psychiatry, University of Tübingen, Germany; LEAD Graduate School and Training Center, Tübingen, Germany.
- Fisher D Department of Psychology, Mount Saint Vincent University, and Department of Psychiatry, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
- Giordano GM Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
- Guntekin B Department of Biophysics, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
- Imperatori C Cognitive and Clinical Psychology Laboratory, Department of Human Science, European University of Rome, Rome, Italy.
- Ishii R Department of Psychiatry Osaka University Graduate School of Medicine, Osaka, Japan.
- Kajosch H Laboratoire de Psychologie Médicale et d'Addictologie, ULB Neuroscience Institute (UNI), CHU Brugmann-Université Libre de Bruxelles (U.L.B.), Belgium.
- Kiang M Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
- López-Caneda E Psychological Neuroscience Laboratory, Center for Research in Psychology, School of Psychology, University of Minho, Braga, Portugal.
- Missonnier P Mental Health Network Fribourg (RFSM), Sector of Psychiatry and Psychotherapy for Adults, Marsens, Switzerland.
- Mucci A Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
- Olbrich S Psychotherapy and Psychosomatics, Department for Psychiatry, University Hospital Zurich, Zurich, Switzerland.
- Otte G Group "Neurotope", Ghent, Belgium.
- Perrottelli A Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
- Pizzuti A Department of Psychology, Sapienza University of Rome, Fondazione Santa Lucia, Rome, Italy.
- Pinal D Psychological Neuroscience Laboratory, Center for Research in Psychology, School of Psychology, University of Minho, Braga, Portugal.
- Salisbury D Clinical Neurophysiology Research Laboratory, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- Tang Y Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Tisei P Department of Neurosciences, Public Health and Sense Organs (NESMOS), Sapienza University of Rome, Rome, Italy.
- Wang J Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Winkler I Institute of Cognitive Neuroscience and Psychology, Research Centre for Natural Sciences, Budapest, Hungary.
- Yuan J Institute of Brain and Psychological Sciences, Sichuan Normal University, Chengdu, China.
- Pogarell O Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
- 2020-09-25
Published in:
- Clinical EEG and neuroscience. - 2020
COVID-19
event-related oscillations (EROs)
event-related potentials (ERPs)
psychiatry
quantitative EEG (qEEG)
resting state electroencephalography (rsEEG)
English
INTRODUCTION
The global COVID-19 pandemic has affected the economy, daily life, and mental/physical health. The latter includes the use of electroencephalography (EEG) in clinical practice and research. We report a survey of the impact of COVID-19 on the use of clinical EEG in practice and research in several countries, and the recommendations of an international panel of experts for the safe application of EEG during and after this pandemic.
METHODS
Fifteen clinicians from 8 different countries and 25 researchers from 13 different countries reported the impact of COVID-19 on their EEG activities, the procedures implemented in response to the COVID-19 pandemic, and precautions planned or already implemented during the reopening of EEG activities.
RESULTS
Of the 15 clinical centers responding, 11 reported a total stoppage of all EEG activities, while 4 reduced the number of tests per day. In research settings, all 25 laboratories reported a complete stoppage of activity, with 7 laboratories reopening to some extent since initial closure. In both settings, recommended precautions for restarting or continuing EEG recording included strict hygienic rules, social distance, and assessment for infection symptoms among staff and patients/participants.
CONCLUSIONS
The COVID-19 pandemic interfered with the use of EEG recordings in clinical practice and even more in clinical research. We suggest updated best practices to allow safe EEG recordings in both research and clinical settings. The continued use of EEG is important in those with psychiatric diseases, particularly in times of social alarm such as the COVID-19 pandemic.
The global COVID-19 pandemic has affected the economy, daily life, and mental/physical health. The latter includes the use of electroencephalography (EEG) in clinical practice and research. We report a survey of the impact of COVID-19 on the use of clinical EEG in practice and research in several countries, and the recommendations of an international panel of experts for the safe application of EEG during and after this pandemic.
METHODS
Fifteen clinicians from 8 different countries and 25 researchers from 13 different countries reported the impact of COVID-19 on their EEG activities, the procedures implemented in response to the COVID-19 pandemic, and precautions planned or already implemented during the reopening of EEG activities.
RESULTS
Of the 15 clinical centers responding, 11 reported a total stoppage of all EEG activities, while 4 reduced the number of tests per day. In research settings, all 25 laboratories reported a complete stoppage of activity, with 7 laboratories reopening to some extent since initial closure. In both settings, recommended precautions for restarting or continuing EEG recording included strict hygienic rules, social distance, and assessment for infection symptoms among staff and patients/participants.
CONCLUSIONS
The COVID-19 pandemic interfered with the use of EEG recordings in clinical practice and even more in clinical research. We suggest updated best practices to allow safe EEG recordings in both research and clinical settings. The continued use of EEG is important in those with psychiatric diseases, particularly in times of social alarm such as the COVID-19 pandemic.
- Language
-
- English
- Open access status
- bronze
- Identifiers
-
- DOI 10.1177/1550059420954054
- PMID 32975150
- Persistent URL
- https://folia.unifr.ch/global/documents/68935
Statistics
Document views: 59
File downloads:
- Full-text: 0